CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ALA DIAGNOSTICS is developing a groundbreaking diagnostic kit for Multiple Sclerosis, utilizing a patented recombinant protein as a specific biomarker. This test aims to provide a quick, cost-effective, and non-invasive method for early diagnosis, significantly improving patient outcomes and integrating seamlessly into…
Multiple Sclerosis affects around 700,000 people in Europe and 2.8 million worldwide.
It is the most common chronic neurological disease in young adults in developed countries, and the main cause of disability after traffic accidents.Current diagnosis process takes one year (on average) which makes pharmacological treatment start late producing irreversible damage in patients and a worse prognosis.
Combined with the high rate of misdiagnoses (20%), it leads to a healthcare cost of around €20 bil…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
